Search results for "origin"

showing 10 items of 4356 documents

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors. Prospective analysis from a multicentre observational tri…

2020

Background:This prospective, multicentre, observational INVIDIa-2 study is investigating the clinical efficacy of influenza vaccination in advanced-cancer patients receiving immune-checkpoint inhibitors (ICIs), enrolled in 82 Italian centres, from October 2019 to January 2020. The primary endpoint was the incidence of influenza-like illness (ILI) until 30 April 2020. All the ILI episodes, laboratory tests, complications, hospitalizations and pneumonitis were recorded. Therefore, the study prospectively recorded all the COVID-19 ILI events.Patients and methods:Patients were included in this non-prespecified COVID-19 analysis, if alive on 31 January 2020, when the Italian government declared …

0301 basic medicinemedicine.medical_specialtymedicine.medical_treatmentimmune-checkpoint inhibitorsinfluenza-like illnesslcsh:RC254-28203 medical and health sciences0302 clinical medicineCancer immunotherapyInternal medicineMedicineProspective cohort studyCancer stagingOriginal ResearchInfluenza-like illnessbusiness.industrySARS-CoV-2virus diseasesCOVID-19Immunotherapycancer patients; COVID-19; immune-checkpoint inhibitors; influenza-like illness; SARS-CoV-2lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseComorbidityVaccination030104 developmental biologyOncology030220 oncology & carcinogenesisObservational studybusinesscancer patients
researchProduct

Branched-Chain Amino Acid Levels Are Related with Surrogates of Disturbed Lipid Metabolism among Older Men.

2016

Aims/hypothesis: Existing studies suggest that decreased branched-chain amino acid (BCAA) catabolism and thus elevated levels in blood are associated with metabolic disturbances. Based on such information, we have developed a hypothesis how BCAA degradation mechanistically connects to tricarboxylic acid cycle, intramyocellular lipid storage, and oxidation, thus allowing more efficient mitochondrial energy production from lipids as well as providing better metabolic health. We analyzed whether data from aged Finnish men are in line with our mechanistic hypothesis linking BCAA catabolism and metabolic disturbances. Methods: Older Finnish men enriched with individuals having been athletes in y…

0301 basic medicinemedicine.medical_specialtymitokondriotBranched-chain amino acideducationType 2 diabetesBiologyBody fat percentage03 medical and health scienceschemistry.chemical_compoundLipid oxidationlipid oxidationValineInternal medicineDiabetes mellitusenergy metabolismmedicinebranched-chain amino acidsta315Original Researchlcsh:R5-920Catabolismta3141General Medicinemedicine.diseasemetabolic disease3142 Public health care science environmental and occupational healthmitochondria030104 developmental biologyEndocrinologychemistry3121 General medicine internal medicine and other clinical medicinetricarboxylic acid cycleMedicineBlood sugar regulationlcsh:Medicine (General)Frontiers in Medicine
researchProduct

Phosphodiesterase-5 Inhibition Alleviates Pulmonary Hypertension and Basal Lamina Thickening in Rats Challenged by Chronic Hypoxia

2018

javax.xml.bind.JAXBElement@6f8948ff Hypoxia represents both an outcome of cardiopulmonary diseases and a trigger for severe pulmonary complications as pulmonary hypertension. Because nitric oxide (NO) is a critical mediator in the development of pulmonary hypertension, the modulators of its downstream function may become target of pharmacological interventions aimed at alleviating the impact of this condition. Here, we investigate the effects of an early administration of phosphodiesterase-5 inhibitor in rats where pulmonary artery hypertension was induced by chronic exposure to hypoxia. javax.xml.bind.JAXBElement@162dc677 Rats were divided into three groups: normoxic control, hypoxic with …

0301 basic medicinemedicine.medical_specialtynitrites and nitratesPhysiologySildenafilsildenafil030204 cardiovascular system & hematologyphosphodiesterase 5lcsh:PhysiologyNitric oxideendothelial NO synthase; nitric oxide; nitrites and nitrates; phosphodiesterase 5; pulmonary hypertension; pulmonary vascular remodeling; right heart failure; sildenafil03 medical and health scienceschemistry.chemical_compound0302 clinical medicinenitric oxidePhysiology (medical)medicine.arteryInternal medicinepulmonary hypertensionmedicineendothelial NO synthaseOriginal ResearchCardiopulmonary diseaseLunglcsh:QP1-981business.industryright heart failureHypoxia (medical)medicine.diseasePulmonary hypertension030104 developmental biologymedicine.anatomical_structurechemistryVentriclePulmonary arteryCardiologymedicine.symptombusinesspulmonary vascular remodelingFrontiers in Physiology
researchProduct

Effects of More-Affected vs. Less-Affected Motor Cortex tDCS in Parkinson’s Disease

2017

Objective. To evaluate therapeutic potential of different montages of transcranial direct current stimulation (tDCS) in Parkinson’s Disease (PD) patients with asymmetric motor symptoms. Materials and Methods. Fourteen patients with asymmetric PD underwent, while on treatment, seven separate sessions including electrophysiological and clinical evaluation at baseline and after anodal, cathodal and sham tDCS of the primary motor cortex (M1) of the two hemispheres. Changes in motor cortical excitability were evaluated by transcranial magnetic stimulation. Effects on motor symptoms were assessed by testing finger tapping and upper limb bradykinesia, and by using the Italian validated Movement Di…

0301 basic medicinemedicine.medical_specialtynon-invasive brain stimulationParkinson's diseaseNeurologymedicine.medical_treatmenttDCSlcsh:RC321-57103 medical and health sciencesBehavioral Neuroscience0302 clinical medicinePhysical medicine and rehabilitationmotor cortexmedicineParkinsonâ s diseaselcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBiological PsychiatryOriginal ResearchTranscranial direct-current stimulationcortical excitabilitymedicine.diseaseTranscranial magnetic stimulationElectrophysiology030104 developmental biologymedicine.anatomical_structureNeuropsychology and Physiological PsychologyNeurologyPsychiatry and Mental HealthFinger tappingParkinson’s diseaseSettore MED/26 - NeurologiaPrimary motor cortexPsychologyNeuroscience030217 neurology & neurosurgeryMotor cortexCortical excitability; Motor cortex; Non-invasive brain stimulation; Parkinson’s disease; tDCS; Neuropsychology and Physiological Psychology; Neurology; Psychiatry and Mental Health; Biological Psychiatry; Behavioral NeuroscienceNeuroscienceFrontiers in Human Neuroscience
researchProduct

Safflower Yellow and Its Main Component HSYA Alleviate Diet-Induced Obesity in Mice: Possible Involvement of the Increased Antioxidant Enzymes in Liv…

2020

PurposeOxidative stress plays an important role in the pathogenesis of obesity and its associated disorders. Safflower yellow (SY) and hydroxysafflor yellow A (HSYA), the natural compounds isolated from Carthamus tinctorius L., has been found to possess antioxidative and anti-obesity properties. The purpose of the present study is to investigate whether SY and its main component HSYA alleviate obesity by the antioxidant effects.MethodsDiet-induced obese (DIO) mice were treated with 200 mg/kg/d SY or HSYA for 10 weeks. Body weight, fat mass, serum biochemical parameters and superoxide dismutase (SOD) activities were measured. Glucose and insulin tolerance tests were performed. The expression…

0301 basic medicinemedicine.medical_specialtyobesityAntioxidantmedicine.medical_treatmentAdipose tissueCarbohydrate metabolismmedicine.disease_causeliverSuperoxide dismutase03 medical and health sciences0302 clinical medicineantioxidant enzymesInternal medicinemedicinePharmacology (medical)Original ResearchPharmacologysafflower yellow (SY)biologyChemistryCarthamuslcsh:RM1-950Metabolismbiology.organism_classificationadipose tissue030104 developmental biologyEndocrinologylcsh:Therapeutics. Pharmacology030220 oncology & carcinogenesishydroxysafflor yellow A (HSYA)biology.proteinLiver functionOxidative stressFrontiers in Pharmacology
researchProduct

Corticoperipheral neuromuscular disconnection in obstructive sleep apnoea.

2020

Abstract The roles of central nervous mechanisms and cortical output in obstructive sleep apnoea remain unclear. We addressed corticomuscular coupling between cortical sensorimotor areas and lower facial motor units as a mechanistic pathway and as a possible surrogate marker of corticoperipheral motor control in obstructive sleep apnoea. In this exploratory cross-sectional retrospective study, we analysed EEG (C3 and C4 leads) and chin EMG from polysomnography recordings in 86 participants (22 females; age range: 26–81 years): 27 with mild (respiratory disturbance index = 5–15 events/h), 21 with moderate (15–30 events/h) and 23 with severe obstructive sleep apnoea (>30 events/h) and 15 cont…

0301 basic medicinemedicine.medical_specialtyobstructive sleep apnoeacorticalPolysomnography03 medical and health sciences0302 clinical medicineInternal medicineRespiratory disturbance indexmedicinecouplingSleep Stagesmedicine.diagnostic_testbusiness.industryGeneral EngineeringMotor controlmedicine.diseasemotorMotor unitObstructive sleep apneaAutonomic nervous system030104 developmental biologyBreathingCardiologyOriginal Articleneuromuscularbusiness030217 neurology & neurosurgeryBrain communications
researchProduct

Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onse…

2018

Background: Primary aim was to investigate the diagnostic value of PAS-positive vacuolated lymphocytes on blood smear in Late Onset Pompe Disease (LOPD) patients and, secondly, to evaluate its potential utility in monitoring treatment effects.Methods: We examined blood smear of 26 LOPD patients. We evaluated 10 treated and 16 untreated LOPD patients. Among the latter group, 7 patients later initiated ERT and were tested again 6 months after start. Blood smear was also sampled from 82 controls and 19 patients with other muscle glycogenoses (MGSDs). PAS staining was used to evaluate: (1) presence of lymphocytes with glycogen-filled vacuoles, (2) quantification of vacuolated lymphocytes.Result…

0301 basic medicinemedicine.medical_specialtytherapeutic monitoringBlood smear; LOPD screening test; PAS-positive lymphocytes; Pompe disease; Therapeutic monitoring; Neurology; Neurology (clinical)Late onsetPeriodic acid–Schiff stainDiseasePAS-positive lymphocytesGastroenterologylcsh:RC346-429Vacuolated Lymphocytes03 medical and health sciences0302 clinical medicineInternal medicineBlood smear; LOPD screening test; PAS-positive lymphocytes; Pompe disease; Therapeutic monitoringmedicineScreening toolLOPD screening testlcsh:Neurology. Diseases of the nervous systemOriginal Researchbusiness.industryPompe diseasePredictive value030104 developmental biologyBlood smearNeurologyblood smearBiomarker (medicine)Neurology (clinical)business030217 neurology & neurosurgeryFrontiers in neurology
researchProduct

Blockade of Pannexin-1 Channels and Purinergic P2X7 Receptors Shows Protective Effects Against Cytokines-Induced Colitis of Human Colonic Mucosa

2018

Introduction: The pannexin-1 (Panx1) channels are found in many cell types, and ATP released from these channels can act on nearby cells activating purinergic P2X7 receptors (P2X7R) which lead to inflammation. Although Panx1 and P2X7R are implicated in the process of inflammation and cell death, few studies have looked at the role they play in inflammatory bowel disease in human. Hence, the aim of the present study was to investigate the function of Panx1 and P2X7R in an ex vivo colitis model developed from human colonic mucosal explants.Materials and Methods: Healthy human colonic mucosal strips (4 × 10 mm) were incubated in carbogenated culture medium at 37°C for 16 h. Proinflammatory cyt…

0301 basic medicinemedicine.medical_specialtytissue explantsCryptInflammationInflammatory bowel diseasecolonic inflammationProinflammatory cytokine03 medical and health sciencesInternal medicinemedicinePharmacology (medical)ColitisOriginal ResearchPharmacologyTight junctionChemistrylcsh:RM1-950Purinergic receptorpannexin-1medicine.diseaselcsh:Therapeutics. Pharmacology030104 developmental biologyEndocrinologyP2X7 receptorhuman colitisTumor necrosis factor alphamedicine.symptomFrontiers in Pharmacology
researchProduct

Factors associated with nocturia-related quality of life in men with lower urinary tract symptoms and treated with tamsulosin oral controlled absorpt…

2020

Nocturia impairs quality of life (QoL). We have performed a non-interventional study in which men with lower urinary tract symptoms (LUTS) were treated for at least 3 months with tamsulosin oral controlled absorption system (0.4 mg q.d.). Other than observing efficacy and tolerability of this drug formulation, the study was designed to explore the relative roles of number of nocturia episodes and of non-urological causes of nocturia on nocturia-related QoL at baseline and treatment-associated changes thereof. The study enrolled 5775 men seeking treatment of their LUTS. Tamsulosin improved LUTS, e.g. International Prostate Symptom Score from 19.5 +/- 5.9 to 10.1 +/- 4.9 (means +/- SD). This …

0301 basic medicinemedicine.medical_specialtyurologic and male genital diseases03 medical and health sciences0302 clinical medicineQuality of lifeLower urinary tract symptomsTamsulosinInternal medicinemedicineNocturiaPharmacology (medical)Original ResearchPharmacologyHeart Failurebusiness.industrylcsh:RM1-950DiabetesSleep apneamedicine.diseasehumanitiesfemale genital diseases and pregnancy complications030104 developmental biologylcsh:Therapeutics. PharmacologyTolerability030220 oncology & carcinogenesisHeart failureQuality of LifeInternational Prostate Symptom ScoreNocturiamedicine.symptombusinessMale Lower Urinary Tract Symptomsmedicine.drug
researchProduct

In Metastatic Non-small cell Lung Cancer Platinum-Based Treated Patients, Herbal Treatment Improves the Quality of Life. A Prospective Randomized Con…

2017

Background: According to clinical experience, Traditional Chinese Medicine (TCM) herbs added to platinum-based therapy (PBT) improve the Quality of Life (QOL) in metastatic non-small cell lung cancer (NSCLC) patients, but this must be prospectively validated.Patients and Methods: Based on clinical impressions regarding the effect of adding TCM herbs to platinum-based chemotherapy, we anticipated that 2 × 21 patients would be sufficient to obtain significant results with an α < 0.05 and power (1 - β) of 90%. To be on the safe side, we enrolled at least 28 patients in each group. In a prospective randomized controlled trial, 61 uniquely defined consecutive patients (PBT+PLACEBO, N = 32; PB…

0301 basic medicinemedicine.medical_specialtyvomitingNauseamedicine.medical_treatmentTraditional Chinese medicinePlaceboGastroenterology03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineMedicineTraditional Chinese MedicinePharmacology (medical)Lung cancerOriginal ResearchPharmacologyChemotherapynon-small cellbusiness.industrylcsh:RM1-950medicine.diseasenauseaSurgerymetastaticClinical triallung cancer030104 developmental biologylcsh:Therapeutics. Pharmacology030220 oncology & carcinogenesisVomitingQuality of Lifemedicine.symptombusinessFrontiers in Pharmacology
researchProduct